SynthesisBMC women's health2026
Telerehabilitation in the management of urinary incontinence in women: a narrative review.
Synthesis in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of mobile apps for urinary incontinence in women: a meta-analysis of randomized controlled trials.Frontiers in public health · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urinary incontinence (UI) is a prevalent condition affecting millions worldwide, particularly women, with significant impacts on physical, psychological, and socioeconomic aspects of life (Haylen et al., Neurourol Urodyn 29:4–20, 2010; Aoki et al., Nat Rev Dis Primers 3:1–20, 2017). Conventional management includes behavioral therapy, pelvic floor muscle training (PFMT), and pharmacological interventions, but barriers such as social stigma, access to specialists, and poor treatment adherence persist (Nitti Rev Urol 3, 2001; Sinclair et al., Obstet Gynaecol 13:143-8, 2011; Minassian et al., 111:324-31, 2008; Milsom et al., Eur Urol 65:79-95, 2014). Telerehabilitation—defined as the delivery of rehabilitation services via electronic information and communication technologies (e.g., video conferencing and phone calls for improved access; mobile apps, websites, and virtual reality (VR) for enhanced engagement and self-management)—offers a potentially promising alternative to overcome these obstacles (Buckingham et al., JMIRx Med 3:e30516, 2022). This narrative review synthesizes evidence from studies conducted between January 2000 and November 6, 2025 on telerehabilitation’s role in UI management in women, focusing on stress UI, PFMT efficacy, and comparative outcomes with in-person therapy. It addresses gaps in prior systematic reviews by focusing on patient-centered designs and cultural adaptations. Key findings from 25 included studies indicate that telerehabilitation is feasible, effective in reducing UI symptoms, improving quality of life (QoL), and enhancing adherence, particularly through mobile apps and group-based interventions (Asklund et al., Neurourol Urodyn 36:1369-76, 2017; Sjostrom et al., BJU Int 112:362-72, 2013; Hoffman et al., Gynecol Scand 96:1180-7, 2017). However, limitations include heterogeneity in interventions, small sample sizes in many studies, lack of long-term data, absence of male participants, limited validation in rural or cognitively impaired populations, and insufficient cultural adaptations for diverse groups. Recommendations include developing tailored telerehabilitation programs incorporating biofeedback and interdisciplinary approaches to address UI holistically. This review highlights telerehabilitation’s potential as a scalable, cost-effective intervention, particularly post-COVID-19, and calls for further research in diverse female populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.